NCEL logo

NewcelX Ltd.

NCEL
Healthcare|Biotechnology|CH
$2.72
-0.17 (-5.73%)
DCF Value
$0.18
Graham Number
$2.39
Cash / Share
$0.12

Ownership Breakdown

100.0%
Float
0.5M
Shares Outstanding
0.5M
Float Shares

Major Holders (21)

Combined: 139.7%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Julien RuggieriIndividual25.30%1,316,267May 4, 202613D/G
League Jinn SarlCorporation25.30%1,316,267May 4, 202613D/G
Michel RevelIndividual20.20%940,787Nov 14, 202513D/G
Steven BoydHC, IN9.99%129,475Nov 14, 202413D/G
Armistice Capital, LLCIA, OO9.99%129,475Nov 14, 202413D/G
Jeff EastonIndividual8.10%103,530Nov 14, 202413D/G
Lind Global Partners II LLCOther8.10%103,530Nov 14, 202413D/G
Lind Global Fund II LPPartnership8.10%103,530Nov 14, 202413D/G
Clover Wolf Capital - Limited PartnershipPartnership7.50%343,120Nov 7, 202513D/G
Adi WolfIndividual7.50%343,120Nov 7, 202513D/G
Ronen TwitoIndividual6.00%272,399Nov 13, 202513D/G
Lampert Mark NIndividual0.60%28,732Nov 4, 202513D/G
BVF GP Holdings LLCOther0.60%26,942Nov 4, 202513D/G
BVF Partners L P/IlIA, PN0.60%28,732Nov 4, 202513D/G
BVF Inc/IlCorporation0.60%28,732Nov 4, 202513D/G
Biotechnology Value Fund L PPartnership0.30%15,196Nov 4, 202513D/G
BVF I GP LLCOther0.30%15,196Nov 4, 202513D/G
Biotechnology Value Fund II LPPartnership0.30%11,746Nov 4, 202513D/G
BVF II GP LLCOther0.30%11,746Nov 4, 202513D/G
BVF Partners OS Ltd.Corporation0.03%1,334Nov 4, 202513D/G
Biotechnology Value Trading Fund OS LPPartnership0.03%1,334Nov 4, 202513D/G

Insider Trades (14)

Last 4 quarters: 327,271 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Samuel OlivierdirectorApr 27, 2026BUY114,545$3.02$346.5KForm 4
Samuel OlivierdirectorApr 27, 2026BUY81,818$2.75$225.0KForm 4
Revel Micheldirector, 10 percent owner, officer: CSO and DirectorApr 27, 2026BUY54,545$2.75$150.0KForm 4
Revel Micheldirector, 10 percent owner, officer: CSO and DirectorApr 27, 2026BUY76,363$3.02$231.0KForm 4
Molakandov KfirVP of R&DMar 18, 2026OTHER11,396$7.62$86.8KForm 4
Iohan Eran IsraeldirectorMar 18, 2026OTHER9,117$7.62$69.5KForm 4
Galili TamardirectorMar 18, 2026OTHER9,117$7.62$69.5KForm 4
Twito Ronendirector, officer: Chairman and CEOMar 18, 2026OTHER0——Form 4
Revel Micheldirector, officer: CSO and DirectorMar 18, 2026OTHER0——Form 4
Revel Micheldirector, officer: CSO and DirectorMar 18, 2026OTHER9,117$7.62$69.5KForm 4
Hagai OmriChief Financial OfficerMar 18, 2026OTHER11,396$7.62$86.8KForm 4
Samuel OlivierdirectorMar 18, 2026OTHER13,676$7.62$104.2KForm 4
Oren LioradirectorMar 18, 2026OTHER9,117$7.62$69.5KForm 4
Zwyer AlexanderdirectorMar 18, 2026OTHER50,143$7.62$382.1KForm 4